Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOP for Verifying Regulatory Compliance for Imported Raw Materials – V 2.0

Posted on By

SOP for Verifying Regulatory Compliance for Imported Raw Materials – V 2.0

Standard Operating Procedure for Verifying Regulatory Compliance for Imported Raw Materials

Department Quality Assurance / Regulatory Affairs / Procurement / Warehouse
SOP No. SOP/RM/044/2025
Supersedes SOP/RM/044/2022
Page No. Page 1 of 15
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for verifying the regulatory compliance of imported raw materials. Compliance verification is essential to ensure that all imported materials meet international and national regulatory standards, including those set by the FDA, EMA, WHO, and other relevant authorities. This SOP ensures:

  • Systematic verification of documentation for all imported raw materials.
  • Compliance with international and national regulations for raw material imports.
  • Timely identification of non-compliance issues and implementation of corrective actions.
  • Coordination between Regulatory Affairs, Quality Assurance (QA), Procurement, and Warehouse teams.

2. Scope

This SOP applies to all raw materials imported into the facility, including active pharmaceutical ingredients (APIs), excipients, chemicals, solvents, and packaging materials. It includes:

  • Verification of import documentation, including Certificates of Analysis (CoA), Certificates of Origin (CoO), and regulatory approvals.
  • Inspection and documentation of imported raw materials at the point of receipt.
  • Responsibilities for handling non-compliant materials and initiating corrective actions.

3. Responsibilities

Regulatory Affairs Team:

  • Verify that all imported raw materials comply with international and national regulatory requirements.
  • Ensure that suppliers provide valid regulatory documentation, including import permits and certificates.
  • Coordinate with QA to resolve any compliance issues identified during material receipt.
  • Quality Assurance (QA) Team:

    • Review import documentation provided by Regulatory Affairs and Procurement.
    • Ensure that all imported raw materials meet internal quality standards and regulatory requirements.
    • Approve or reject imported raw materials based on compliance verification.
  • Procurement Department:

    • Ensure that suppliers provide complete and accurate regulatory documentation for all imported materials.
    • Coordinate with Regulatory Affairs and QA to resolve documentation discrepancies.
  • Warehouse Personnel:

    • Inspect imported raw materials upon receipt for compliance with shipping and labeling regulations.
    • Segregate and quarantine non-compliant materials pending QA review.
  • 4. Accountability

    The Regulatory Affairs Manager is responsible for verifying the compliance of imported raw materials with all applicable regulatory requirements. The QA Manager holds the authority to approve or reject imported materials based on compliance verification. The Procurement Manager is accountable for ensuring that suppliers provide accurate and complete regulatory documentation, while the Warehouse Manager is responsible for the proper handling of imported materials upon receipt.

    5. Procedure

    5.1 Pre-Shipment Compliance Verification

    1. Review of Supplier Documentation

      1. Regulatory Affairs reviews supplier documentation before shipment, including:
        • Valid Certificates of Analysis (CoA) and Certificates of Origin (CoO).
        • Import permits and licenses, if required.
        • Supplier compliance with international standards such as GMP, FDA, EMA, or WHO guidelines.
      2. Ensure that all regulatory documentation is up-to-date and complete before approving the shipment.
    2. Coordination with Procurement and Suppliers

      1. Procurement ensures that suppliers provide all necessary documentation before shipment.
      2. Coordinate with Regulatory Affairs to address any missing or incomplete documentation before shipment approval.

    5.2 Verification Upon Material Receipt

    1. Initial Inspection by Warehouse Personnel

      1. Upon receipt of imported raw materials, Warehouse personnel perform the following checks:
        • Verify that shipping labels, packaging, and documentation match the purchase order (PO) and regulatory requirements.
        • Inspect materials for signs of damage or contamination during transport.
        • Segregate non-compliant or damaged materials and move them to the quarantine area.
    2. Documentation Review by QA and Regulatory Affairs

      1. QA and Regulatory Affairs review the following documents upon receipt:
        • Certificates of Analysis (CoA) and Certificates of Origin (CoO).
        • Import permits, licenses, and customs clearance documents.
        • Regulatory compliance certificates (e.g., GMP, FDA, EMA).
      2. Document the verification results in the Imported Material Compliance Log (Annexure-1).

    5.3 Handling Non-Compliant Imported Materials

    1. Identification and Quarantine of Non-Compliant Materials

      1. If materials are found non-compliant during inspection:
        • Label the materials as “QUARANTINED – NON-COMPLIANT” and move them to the quarantine area.
        • Document the non-compliance in the Non-Compliance Report (Annexure-2).
      2. Notify Regulatory Affairs and Procurement of the non-compliance for further investigation.
    2. Supplier Communication and Corrective Actions

      1. Procurement contacts the supplier to address non-compliance issues and requests corrective actions.
      2. Regulatory Affairs ensures that suppliers provide updated documentation or rectifications as required.
      3. Document all corrective actions and supplier communications for audit purposes.

    5.4 Final Disposition of Imported Materials

    1. Approval or Rejection of Materials

      1. QA and Regulatory Affairs review the compliance status and determine the final disposition:
        • Approved materials are labeled and moved to designated storage areas.
        • Rejected materials are labeled and moved to the rejection area with proper documentation.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • QC: Quality Control
    • CoA: Certificate of Analysis
    • CoO: Certificate of Origin
    • PO: Purchase Order

    7. Documents

    1. Imported Material Compliance Log (Annexure-1)
    2. Non-Compliance Report (Annexure-2)
    3. Certificates of Analysis (CoA) and Certificates of Origin (CoO)
    4. Import Permits, Licenses, and Customs Clearance Documents

    8. References

    • 21 CFR Part 211 – Current GMP for Finished Pharmaceuticals (US FDA)
    • EU GMP Guidelines Part I – Basic Requirements for Medicinal Products
    • ICH Q7 – GMP for Active Pharmaceutical Ingredients
    • WHO Guidelines on the Importation of Pharmaceuticals
    • Company-Specific Regulatory and Quality Policies

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Imported Material Compliance Log

    Date Supplier Name Material Name Batch Number PO Number CoA Verified Regulatory Compliance Final Disposition Remarks
    01/02/2025 ABC Chemicals API-X X-2025-001 PO-12345 Yes Compliant Approved Released to Storage
    02/02/2025 XYZ Pharma Excipient-Y Y-2025-002 PO-67890 No Non-Compliant Quarantined Pending Supplier Documentation

    Annexure-2: Non-Compliance Report

    Report Number Date Material Name Batch Number Description of Non-Compliance Corrective Action Final Disposition Remarks
    NCR-001/2025 01/02/2025 API-X X-2025-001 None N/A Approved N/A
    NCR-002/2025 02/02/2025 Excipient-Y Y-2025-002 Missing CoA Supplier to Resubmit CoA Pending Awaiting Supplier Response

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
    01/01/2024 1.0 Initial Version New SOP Creation QA Head All All Established procedures for verifying regulatory compliance of imported raw materials.
    01/02/2025 2.0 Added Detailed Corrective Action Procedures Standardization of Document QA Head All All Enhanced procedures for handling non-compliant imported materials and supplier communication.
    See also  SOP for Ensuring Compliance with FDA and WHO-GMP Storage Guidelines - V 2.0
    Raw Material Warehouse V 2.0 Tags:Audit compliance in material storage, Contamination prevention in warehouses, Documentation in warehouse operations, Emergency procedures in warehouses, Equipment maintenance in warehouses, FIFO method in inventory, Handling of hazardous materials, Inventory management SOP, Labeling requirements in warehouses, Loading and unloading procedures, Material inspection protocol, Material receiving process, Material segregation guidelines, Pest control in storage areas, Quality control in warehousing, Raw material handling SOP, Return material handling SOP, Safety procedures for material handling, Security measures for stored materials, Spill response procedures, Storage conditions for raw materials, Temperature and humidity control in storage, Training for warehouse personnel, Warehouse storage procedures, Waste management in warehouses

    Post navigation

    Previous Post: Ointments: SOP for Disassembling and Cleaning Filling Machines – V 2.0
    Next Post: SOP for Emulsion Formulation Screening

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version